Literature DB >> 10727713

Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells.

F Deák1, B Lasztóczi, P Pacher, G L Petheö, A Spät.   

Abstract

Fluoxetine, an antidepressant which is used world-wide, is a prominent member of the class of selective serotonin re-uptake inhibitors. Recently, inhibition of voltage-gated Na(+) and K(+) channels by fluoxetine has also been reported. We examined the effect of fluoxetine on voltage-gated calcium channels using the patch-clamp technique in the whole-cell configuration. In hippocampal pyramidal cells, fluoxetine inhibited the low-voltage-activated (T-type) calcium current with an IC(50) of 6.8 microM. Fluoxetine decreased the high-voltage-activated (HVA) calcium current with an IC(50) between 1 and 2 microM. Nifedipine and omega-conotoxin GVIA inhibited the HVA current by 24% and 43%, respectively. Fluoxetine (3 microM), applied in addition to nifedipine or omega-conotoxin, further reduced the current. When fluoxetine (3 microM) was applied first neither nifedipine nor omega-conotoxin attenuated the remaining component of the HVA current. This observation indicates that fluoxetine inhibits both L- and N-type currents. In addition, fluoxetine inhibited the HVA calcium current in carotid body type I chemoreceptor cells and pyramidal neurons prepared from prefrontal cortex. In hippocampal pyramidal cells high K(+)-induced seizure-like activity was inhibited by 1 microM fluoxetine; the mean burst duration was shortened by an average of 44%. These results provide evidence for inhibition of T-, N- and L-type voltage-gated calcium channels by fluoxetine at therapeutically relevant concentrations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727713     DOI: 10.1016/s0028-3908(99)00206-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  30 in total

Review 1.  Calcium channel blockers and pain therapy.

Authors:  B Cox
Journal:  Curr Rev Pain       Date:  2000

2.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

3.  Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells.

Authors:  Imju Jeong; Shin Hee Yoon; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-04-27       Impact factor: 3.000

4.  Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.

Authors:  Hugo Poulin; Iva Bruhova; Quadiri Timour; Olivier Theriault; Jean-Martin Beaulieu; Dominique Frassati; Mohamed Chahine
Journal:  Mol Pharmacol       Date:  2014-07-15       Impact factor: 4.436

5.  Selective serotonin reuptake inhibitors facilitate ANO6 (TMEM16F) current activation and phosphatidylserine exposure.

Authors:  Hyun Jong Kim; Ikhyun Jun; Jae Seok Yoon; Jinsei Jung; Yung Kyu Kim; Woo Kyung Kim; Byung Joo Kim; Jaewoo Song; Sung Joon Kim; Joo Hyun Nam; Min Goo Lee
Journal:  Pflugers Arch       Date:  2015-01-30       Impact factor: 3.657

6.  Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

7.  Lacidipine attenuates reserpine-induced depression-like behavior and oxido-nitrosative stress in mice.

Authors:  Kunal Khurana; Nitin Bansal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-11       Impact factor: 3.000

Review 8.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 9.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

10.  Effect of acute and chronic treatment with milnacipran potentiates the anticonvulsant activity of conventional antiepileptic drugs in the maximal electroshock-induced seizures in mice.

Authors:  Kinga K Borowicz; Kamila Furmanek-Karwowska; Marta Morawska; Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.